Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms Appear
UCSF scientists have found a set of autoantibodies that emerge in some MS patients years before symptoms.
University of California San Francisco
Give to UCSFUCSF scientists have found a set of autoantibodies that emerge in some MS patients years before symptoms.
New CAR-T gene therapy techniques could extend survival for patients with glioblastoma.
A study reveals the life-altering impact of COVID-19 on individuals who developed severe illness, the majority of whom had to be placed on mechanical ventilators. Two-thirds still had physical, psychiatric, and cognitive problems for up to a year later.
Intentional flu vaccine messaging, such as a brief video, flyer, or a scripted provider question, is enough to persuade many who visit emergency departments to receive the vaccination.
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended.
A first of its kind study finds that the COVID vaccine is safe to administer during pregnancy, causing no abnormal delays when the infants were tested at 12 months and again at 18 months.
UCSF will launch the world’s first tissue bank with samples donated by patients with long COVID.
Cancer immunotherapy is hindered by the fact that engineered immune cells often get worn out and depleted before they've killed a tumor. A UCSF team has identified mutations that give cancerous lymphoma T-cells their superpower and transfer those genes into engineered, therapeutic immune cells.
UC San Francisco’s Thomas G. Martin, MD, a leading expert in blood cancers, has received a grant of nearly $4.6 million from the California Institute of Regenerative Medicine (CIRM) to produce a CAR T
A team of researchers from UC San Francisco has found that Paxlovid did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.
The new JN.1 COVID-19 variant is now estimated to make up about 20% of cases in the United States. Three UCSF experts offer advice on vaccines, masking, and other ways to protect yourself.
Fortified stem cells. Enhanced memory. A longevity hormone. UCSF researchers are finding out whether we can cancel – or at least delay – old age.
The FDA's recent ruling of phenylephrine as ineffective has led major pharmacies and retailers to pull common cold medicines from their shelves.
Thirty-two UCSF scientists are among the most influential individuals in their respective fields, according to the most recent analysis of research citations by the science and intellectual property company, Clarivate.
University of California prostate cancer experts will share clinical insights at the first annual PSMA Conference, “PSMA PET and RLT: Present and Future.” The conference will take place online and in
The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities.
New research shows that in the U.S., the longevity gap between women and men has been widening for more than a decade, with women outliving men by an average of six years.
A collaboration is between two biomedical researchers bridges the laboratory and clinic to advance the science of itch, allergy and asthma.
A phase 1 trial shows promise in treating metastatic prostate cancer with a single priming dose of radioligand therapy and immunotherapy.
UCSF's Adam Boxer, MD, PhD, and Harvard neurologist Reisa Sperling, MD, review the history of clinical trials over the past 30 years in Alzheimer’s research with what was learned and how new biomarkers and clinical trial approaches are being used to find more effective treatments in a more efficient way than in the past.
UCSF researchers developed a new neighborhood-based model of care that brings medicine to people immediately after being diagnosed with hepatitis C.
A study found that children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab.
Scientists found that the nervous system tamps down allergic response, which could change how asthma, Crohn’s and other inflammatory diseases are treated.
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.